← Back to Search

Low Mindfulness for Chronic Pain

N/A
Waitlist Available
Led By Katherine Bercovitz, MA
Research Sponsored by Harvard University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 minutes
Awards & highlights

Study Summary

This trial will test whether mindfulness can help people with chronic pain by teaching them to pay attention to their pain sensations in a non-judgmental way. The hope is that this will decrease the intensity and frequency of chronic pain, and improve well-being and health-related quality of life.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 minutes
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 minutes for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Brief Pain Inventory- Short Form
Multidimensional Health Locus of Control Scale - Form C (MHLC-Form C)
Pain Beliefs and Perceptions Inventory (PBAPI)
+1 more
Secondary outcome measures
Langer Mindfulness Scale- 14 item (LMS-14)
Pain Catastrophizing Scale (PCS)

Trial Design

3Treatment groups
Experimental Treatment
Active Control
Group I: Low MindfulnessExperimental Treatment1 Intervention
All participants in this condition will complete all measures online at four different points in time, including one narrative response at T1. They will also be instructed to respond to diary-type text messaging questions (some related to pain) twice daily for six days.
Group II: High MindfulnessExperimental Treatment1 Intervention
All participants in this condition will complete all measures online at four different points in time, including one narrative response at T1. They will also be instructed to complete a mindfulness intervention at home and respond to diary-type text messaging questions (all including questions about pain) twice daily for six days.
Group III: Active controlActive Control1 Intervention
All participants in this condition will complete all measures online at four different points in time, including one narrative response at T1. They will also be instructed to respond to diary-type text messaging questions (none about pain) twice daily for six days.

Find a Location

Who is running the clinical trial?

Harvard UniversityLead Sponsor
229 Previous Clinical Trials
474,205 Total Patients Enrolled
1 Trials studying Chronic Pain
490 Patients Enrolled for Chronic Pain
Katherine Bercovitz, MAPrincipal InvestigatorHarvard University
Karyn Gunnet-Shoval, PhDPrincipal InvestigatorHarvard University
1 Previous Clinical Trials
160 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is there still time to join this clinical experiment?

"According to clinicaltrials.gov, this medical study is no longer recruiting patients; the trial was first posted on April 20th 2018 and last modified October 25th 2021. Nevertheless, there are still 404 other trials actively enrolling participants currently."

Answered by AI
Recent research and studies
~43 spots leftby Apr 2025